Insiders seem to have made the most of their holdings by selling CN¥29m worth of WuXi AppTec Co., Ltd. (SHSE:603259) stock at an average sell price of CN¥149 during the past year. The company's market valuation decreased by CN¥22b after the stock price dropped 7.2% over the past week, but insiders were spared from painful losses.
Although we don't think shareholders should simply follow insider transactions, we do think it is perfectly logical to keep tabs on what insiders are doing.
See our latest analysis for WuXi AppTec
The Last 12 Months Of Insider Transactions At WuXi AppTec
Over the last year, we can see that the biggest insider sale was by the Vice Chairman of the Board & Global Chief Investment Officer, Edward Hu, for CN¥5.3m worth of shares, at about CN¥153 per share. While insider selling is a negative, to us, it is more negative if the shares are sold at a lower price. The good news is that this large sale was at well above current price of CN¥93.63. So it may not shed much light on insider confidence at current levels.
WuXi AppTec insiders didn't buy any shares over the last year. The chart below shows insider transactions (by companies and individuals) over the last year. By clicking on the graph below, you can see the precise details of each insider transaction!
SHSE:603259 Insider Trading Volume August 2nd 2022
If you like to buy stocks that insiders are buying, rather than selling, then you might just love this free list of companies. (Hint: insiders have been buying them).
Insider Ownership Of WuXi AppTec
Many investors like to check how much of a company is owned by insiders. I reckon it's a good sign if insiders own a significant number of shares in the company. It's great to see that WuXi AppTec insiders own 8.2% of the company, worth about CN¥22b. Most shareholders would be happy to see this sort of insider ownership, since it suggests that management incentives are well aligned with other shareholders.
So What Do The WuXi AppTec Insider Transactions Indicate?
There haven't been any insider transactions in the last three months -- that doesn't mean much. While we feel good about high insider ownership of WuXi AppTec, we can't say the same about the selling of shares. So while it's helpful to know what insiders are doing in terms of buying or selling, it's also helpful to know the risks that a particular company is facing. For instance, we've identified 2 warning signs for WuXi AppTec (1 is a bit concerning) you should be aware of.
Of course, you might find a fantastic investment by looking elsewhere. So take a peek at this free list of interesting companies.
For the purposes of this article, insiders are those individuals who report their transactions to the relevant regulatory body. We currently account for open market transactions and private dispositions, but not derivative transactions.
Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team (at) simplywallst.com.
This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.
內部人士似乎通過拋售價值2900萬元的CN藥明康德股份有限公司。(上海證券交易所:603259)過去一年平均售價149元的股票。在過去一週股價下跌7.2%後,該公司市值減少了220億元人民幣,但內部人士沒有遭受痛苦的損失。
儘管我們不認為股東應該簡單地跟蹤內幕交易,但我們確實認為,密切關注內部人士的所作所為是完全合乎邏輯的。
參見我們對藥明康德的最新分析
藥明康德最近12個月的內幕交易
在過去的一年裏,我們可以看到,最大的內幕交易是董事會副主席兼全球首席投資官胡以每股約153元的價格購買了價值530萬元的股票。雖然內幕出售是負面的,但對我們來説,如果股票以更低的價格出售,負面影響就更大。好消息是,這筆大筆交易的價格遠遠高於當前93.63元的價格。因此,在目前的水平上,這可能不會讓人對內部人士的信心有太多瞭解。
藥明康德內部人士去年沒有購買任何股票。下面的圖表顯示了過去一年的內幕交易(按公司和個人)。通過點擊下面的圖表,你可以看到每一筆內幕交易的準確細節!
上交所:2022年8月2日內幕交易量603259
如果你喜歡購買內部人士正在買入的股票,而不是拋售,那麼你可能會喜歡這一點免費公司名單。(提示:內部人士一直在買入這些股票)。
藥明康德的內部人所有權
許多投資者喜歡查看一家公司有多少股份是由內部人士持有的。我認為,如果內部人士持有該公司大量股份,這是一個好兆頭。很高興看到藥明康德的內部人士持有該公司8.2%的股份,價值約220億元人民幣。大多數股東將樂於看到這種內部人持股,因為這表明管理層的激勵與其他股東很好地結合在一起。
那麼,藥明康德內幕交易意味着什麼呢?
過去三個月沒有發生任何內幕交易--這並不意味着什麼。雖然我們對藥明康德的高內部人持股感到滿意,但對出售股份的行為就不能説同樣的話了。因此,雖然瞭解內部人士在買入或賣出方面做了什麼是有幫助的,但瞭解一家特定公司面臨的風險也是有幫助的。例如,我們已經確定藥明康德的2個警示標誌(1有點令人擔憂)你應該知道。
當然了,如果你把目光投向別處,你可能會發現這是一筆很棒的投資。所以讓我們來看看這個免費有趣的公司名單。
就本文而言,內部人是指向相關監管機構報告其交易的個人。我們目前負責公開市場交易和私人處置,但不包括衍生品交易。
對這篇文章有什麼反饋嗎?擔心內容嗎? 保持聯繫直接與我們聯繫。或者,也可以給編輯組發電子郵件,地址是implywallst.com。
本文由Simply Wall St.撰寫,具有概括性。我們僅使用不偏不倚的方法提供基於歷史數據和分析師預測的評論,我們的文章並不打算作為財務建議。它不構成買賣任何股票的建議,也沒有考慮你的目標或你的財務狀況。我們的目標是為您帶來由基本面數據驅動的長期重點分析。請注意,我們的分析可能不會將最新的對價格敏感的公司公告或定性材料考慮在內。Simply Wall St.對上述任何一隻股票都沒有持倉。